Will PER follow DXB on a similar journey ?, page-27

“The company has been around for quite a long time, like 20 years, and they’ve had various ups and downs,” Power told *.“But this result is very important for them and was an inflection point, and I agree when they said it would only be the starting line.”Pilcher said the NEU stock price has been severely undervalued for a long time, because people had major doubts whether the company would be able to get positive results from the clinical trials.“We’ve got three analysts covering the stock, and I’m confident that with the latest results, they’re going to update their models and come up with a valuation well north of where the share price is right now.”Besides DXB
Morgans had confidence in NEU
as much as PER “

People laugh at my prediction of >$5 in time
Neu was a 2 c stock before I invested in PER (Anp)
I had 2 mill Neu @ 2.2 c

Now

i sold all my Neu and bought PER at 2c
because I believed that in the long term Per would outshine NEU

Morgans believe Per is the next NEU?